GCG and type 2 diabetes mellitus: Glucagon-like peptide-1 (GLP-1) analogues have been shown to improve glycaemic control, weight loss and in retrospective studies, liver enzymes in patients with type 2 diabetes [9], making them an attractive therapeutic option in NASH.